Advertisement

The Latest

The U.S. Food and Drug Administration has alerted healthcare professionals to stop using certain IV bags of metronidazole, ondansetron and ciprofloxacin due to reports of floating matter and possible contamination in IV bags manufactured by Claris Lifesciences Limited, according to…

Two transmittals issued by the Centers for Medicare and Medicaid Services provided updates to the Hospital Outpatient Prospective Payment System, including clarification of outpatient diagnostic services policies and changes to device and Category III codes to be implemented on July…

A transmittal from the Centers for Medicare & Medicaid Services has listed four new Category III codes for the Hospital Outpatient Prospective Payment System set to take effect on July 1.

The U.S. Food and Drug Administration sent AstraZeneca a Complete Response Letter, rejecting a new drug application for the company's Axanum, according to an AstraZeneca news release.

Advertisement